🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

CFRA lifts AO Smith to Buy, raises target to $90

Published 22/10/2024, 20:58
AOS
-

On Tuesday, CFRA analyst upgraded shares of AO Smith (NYSE:AOS), a manufacturer of water heaters and boilers, from Hold to Buy, adjusting the price target upward to $90 from the previous $87. The revision reflects a positive outlook based on anticipated sales growth and margin expansion.

The analyst cited a forward P/E of 21.5x based on the 2025 earnings per share (EPS) estimate, which represents a premium compared to the historical five-year forward average of 19.6x. The upgrade comes despite a decrease in the company's EPS estimates for 2024 and 2025, with the former reduced by $0.22 to $3.82 and the latter by $0.13 to $4.21.

AO Smith's third-quarter performance showed a 4% year-over-year decline in sales, influenced by lower sales in China and decreased volumes of water heaters in North America. However, this was partially balanced by stronger boiler and water treatment sales in North America and increased sales in India. The third-quarter EPS of $0.82 aligned with consensus estimates.

The report also highlighted AO Smith's shareholder-friendly moves, including the repurchase of 2.9 million shares year-to-date and a recent 6% dividend increase, which marks the 32nd consecutive year of dividend growth. The analyst believes the stock has an attractive upside and views the company's growth opportunities, such as the water treatment segment and exposure to emerging markets, favorably.

In other recent news, A.O. Smith Corporation announced a series of developments that have impacted its financial performance. The company reported a nearly 4% decrease in third-quarter revenue, totaling $902.6 million, and a drop in net income to $120 million. This decline was attributed to weak demand for water heaters in North America and China. The company also revised its full-year adjusted profit forecast, signaling a reduction to between $3.70 and $3.85 per share, primarily due to soft market conditions in China.

Baird, an independent firm, adjusted its financial outlook for A.O. Smith and reduced its price target on the stock from $90.00 to $82.00, maintaining a neutral rating. This followed the company's pre-announcement of its third-quarter results, which fell short of expectations. Despite these challenges, the company announced a 6% increase in its quarterly cash dividend rate to $0.34 per share, demonstrating its commitment to returning capital to shareholders.

A.O. Smith also revised its 2024 earnings forecast following a 4% decline in third-quarter sales. The company cited lower sales in China and North America as the primary reasons for the adjustment. Despite these challenges, A.O. Smith remains optimistic about its growth prospects, particularly in India and its boiler business, following the acquisition of Pureit.

InvestingPro Insights

Adding to the analyst's positive outlook on AO Smith (NYSE:AOS), recent data from InvestingPro provides further context to the company's financial health and market position. The company's P/E ratio of 20.12 aligns closely with the forward P/E mentioned in the article, suggesting consistent valuation metrics.

InvestingPro Tips highlight AO Smith's strong dividend history, having raised its dividend for 16 consecutive years. This reinforces the article's mention of the company's shareholder-friendly approach and recent 6% dividend increase. The current dividend yield stands at 1.73%, with a notable dividend growth of 13.33% over the last twelve months.

Despite the reported sales decline in China and North America, AO Smith maintains a solid financial position. An InvestingPro Tip indicates that the company holds more cash than debt on its balance sheet, which could provide flexibility for future growth initiatives or weathering market fluctuations.

For investors seeking a deeper analysis, InvestingPro offers 11 additional tips for AO Smith, providing a comprehensive view of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.